Susquehanna International Group, LLP Celcuity Inc. Call Options Transaction History

Susquehanna International Group, LLP

  • $688 Billion
  • Q2 2025

Call Options

4 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q2 2025

Aug 14, 2025
BUY
$8.21 - $13.35 $330,042 - $536,670
40,200 New
40,200 $536,000
Q4 2024

Feb 14, 2025
SELL
$12.0 - $16.35 $104,400 - $142,245
-8,700 Reduced 34.94%
16,200 $212,000
Q3 2024

Nov 14, 2024
BUY
$13.98 - $19.15 $348,102 - $476,834
24,900 New
24,900 $371,000
Q1 2024

May 07, 2024
BUY
$13.74 - $21.6 $127,782 - $200,880
9,300 New
9,300 $200,000

Others Institutions Holding CELC

# of Institutions
102
Shares Held
31.6M
Call Options Held
40.2K
Put Options Held
21.5K
View Full List

About Celcuity Inc.

CELC Quotes by TradingView
  • Ticker CELC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 14,941,300
  • Market Cap $684M
  • Description
  • Celcuity Inc., a clinical stage biotechnology company, focuses on the development of molecularly targeted therapies for cancer patients in the United States. The company's CELsignia diagnostic platform uses a patient's living tumor cells to identify the specific abnormal cellular process driving a patient's cancer and the related targeted therap...
More about CELC
Track This Portfolio

Track Susquehanna International Group, LLP Portfolio

Follow Susquehanna International Group, LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Susquehanna International Group, LLP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email